- Joined
- Dec 22, 2007
- Messages
- 8,165
Galantamine alleviates inflammation and insulin resistance in patients with metabolic syndrome in a randomized trial
BACKGROUND. Metabolic syndrome (MetS) is an obesity-driven condition of pandemic proportions that increases the risk of type 2 diabetes and cardiovascular disease. Pathophysiological mechanisms are poorly understood, though inflammation has been implicated ...
www.ncbi.nlm.nih.gov